Katia Mancuso

979 total citations
39 papers, 281 citations indexed

About

Katia Mancuso is a scholar working on Hematology, Molecular Biology and Oncology. According to data from OpenAlex, Katia Mancuso has authored 39 papers receiving a total of 281 indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Hematology, 26 papers in Molecular Biology and 18 papers in Oncology. Recurrent topics in Katia Mancuso's work include Multiple Myeloma Research and Treatments (35 papers), Protein Degradation and Inhibitors (21 papers) and Peptidase Inhibition and Analysis (11 papers). Katia Mancuso is often cited by papers focused on Multiple Myeloma Research and Treatments (35 papers), Protein Degradation and Inhibitors (21 papers) and Peptidase Inhibition and Analysis (11 papers). Katia Mancuso collaborates with scholars based in Italy, Germany and Spain. Katia Mancuso's co-authors include Elena Zamagni, Michèle Cavo, Paola Tacchetti, Lucia Pantani, Serena Rocchi, Beatrice Anna Zannetti, Annamaria Brioli, Carolina Terragna, Annalisa Pezzi and Enrica Borsi and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Katia Mancuso

34 papers receiving 277 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Katia Mancuso Italy 8 240 162 154 25 25 39 281
Serena Rocchi Italy 9 255 1.1× 180 1.1× 157 1.0× 33 1.3× 26 1.0× 31 301
Xenofon Papanikolaou United States 7 241 1.0× 167 1.0× 150 1.0× 50 2.0× 20 0.8× 30 310
Josien C. Regelink Netherlands 4 222 0.9× 83 0.5× 152 1.0× 32 1.3× 42 1.7× 9 261
Ma Teresa Cibeira Spain 8 272 1.1× 224 1.4× 153 1.0× 51 2.0× 13 0.5× 13 306
Vallari Shah United Kingdom 8 172 0.7× 141 0.9× 126 0.8× 40 1.6× 26 1.0× 14 297
María-Victoria Mateos Spain 6 234 1.0× 177 1.1× 161 1.0× 38 1.5× 10 0.4× 13 281
E. Stadtmauer United States 8 271 1.1× 184 1.1× 168 1.1× 55 2.2× 37 1.5× 16 365
Morten Salomo Denmark 10 245 1.0× 195 1.2× 170 1.1× 55 2.2× 10 0.4× 29 344
Cesare Bergonzi Italy 9 229 1.0× 175 1.1× 124 0.8× 40 1.6× 19 0.8× 19 318
Nuria Navarro Coy United Kingdom 6 518 2.2× 428 2.6× 351 2.3× 44 1.8× 12 0.5× 11 567

Countries citing papers authored by Katia Mancuso

Since Specialization
Citations

This map shows the geographic impact of Katia Mancuso's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katia Mancuso with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katia Mancuso more than expected).

Fields of papers citing papers by Katia Mancuso

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Katia Mancuso. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katia Mancuso. The network helps show where Katia Mancuso may publish in the future.

Co-authorship network of co-authors of Katia Mancuso

This figure shows the co-authorship network connecting the top 25 collaborators of Katia Mancuso. A scholar is included among the top collaborators of Katia Mancuso based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Katia Mancuso. Katia Mancuso is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Barbato, Simona, Franca Bigi, Ilaria Rizzello, et al.. (2025). Diagnostic Innovations: Advances in imaging techniques for diagnosis and follow-up of multiple myeloma. Journal of bone oncology. 51. 100669–100669. 1 indexed citations
2.
Mancuso, Katia, Simona Barbato, Francesca Gay, et al.. (2025). Forcing Ahead: Second-Line Treatment Options for Lenalidomide-Refractory Multiple Myeloma. Cancers. 17(7). 1168–1168.
3.
Mancuso, Katia, Paola Tacchetti, Lucia Pantani, et al.. (2025). BISPECIFIC ANTIBODIES AND CART IN MULTIPLE MYELOMA: APPROPRIATE SELECTION OF PATIENTS AND SEQUENCING. Mediterranean Journal of Hematology and Infectious Diseases. 17(1). e2025045–e2025045.
4.
Fiacchini, Mauro, Katia Mancuso, Chiara Sartor, et al.. (2025). Ten-year experience on home care for patients with plasma cell disorders: bringing optimal therapy home. Clinical and Experimental Medicine. 25(1). 179–179.
5.
Barbato, Simona, Ilaria Rizzello, Chiara Sartor, et al.. (2024). Impact of Anti-CD38 Monoclonal Antibody Therapy on CD34+ Hematopoietic Stem Cell Mobilization, Collection, and Engraftment in Multiple Myeloma Patients—A Systematic Review. Pharmaceuticals. 17(7). 944–944. 1 indexed citations
6.
Tacchetti, Paola, Simona Barbato, Ilaria Rizzello, et al.. (2024). Interference of daratumumab and efficacy of plerixafor on haematopoietic stem cell collection in Multiple Myeloma. SHILAP Revista de lepidopterología. 3. 1 indexed citations
7.
Terragna, Carolina, Marina Martello, Elena Zamagni, et al.. (2024). Multi-dimensional scaling techniques unveiled gain1q&loss13q co-occurrence in Multiple Myeloma patients with specific genomic, transcriptional and adverse clinical features. Nature Communications. 15(1). 1551–1551. 5 indexed citations
8.
Brioli, Annamaria, Katia Mancuso, Mascha Binder, et al.. (2023). Pomalidomide combinations are a safe and effective option after daratumumab failure. Journal of Cancer Research and Clinical Oncology. 149(9). 6569–6574. 4 indexed citations
9.
10.
Borsi, Enrica, Marina Martello, Elena Zamagni, et al.. (2023). High levels of CRBN isoform lacking IMiDs binding domain predicts for a worse response to IMiDs-based upfront therapy in newly diagnosed myeloma patients. Clinical and Experimental Medicine. 23(8). 5227–5239. 4 indexed citations
11.
Fazio, Francesca, Serena Rocchi, Ilaria Rizzello, et al.. (2023). Severe SARS-CoV-2 and subsequent fungal infections after CAR T-cell therapy for relapsed/refractory multiple myeloma: a challenging and happy ending fight. Leukemia Research Reports. 21. 100399–100399. 1 indexed citations
12.
Martello, Marina, Enrica Borsi, Luca Dozza, et al.. (2022). Clonal and subclonal TP53 molecular impairment is associated with prognosis and progression in multiple myeloma. Blood Cancer Journal. 12(1). 15–15. 17 indexed citations
13.
Mancuso, Katia, Paola Tacchetti, Lucia Pantani, et al.. (2020). Maintenance therapy with bortezomib and dexamethasone after autotransplantation for high-risk multiple myeloma. Bone Marrow Transplantation. 55(9). 1865–1867. 1 indexed citations
14.
Zannetti, Beatrice Anna, Paola Tacchetti, Lucia Pantani, et al.. (2017). Novel agent-based salvage autologous stem cell transplantation for relapsed multiple myeloma. Annals of Hematology. 96(12). 2071–2078. 3 indexed citations
15.
Zamagni, Elena, Cristina Nanni, Katia Mancuso, et al.. (2015). PET/CT Improves the Definition of Complete Response and Allows to Detect Otherwise Unidentifiable Skeletal Progression in Multiple Myeloma. Clinical Cancer Research. 21(19). 4384–4390. 107 indexed citations
16.
Pantani, Lucia, Annamaria Brioli, Paola Tacchetti, et al.. (2015). Current and emerging triplet combination therapies for relapsed and refractory multiple myeloma. Expert Review of Hematology. 9(3). 315–323. 4 indexed citations
17.
Zamagni, Elena, Cristina Nanni, Paola Tacchetti, et al.. (2014). Positron Emission Tomography With Computed Tomography–Based Diagnosis of Massive Extramedullary Progression in a Patient With High-Risk Multiple Myeloma. Clinical Lymphoma Myeloma & Leukemia. 14(3). e101–e104. 7 indexed citations
18.
19.
Pantani, Lucia, Elena Zamagni, Beatrice Anna Zannetti, et al.. (2013). Bortezomib and dexamethasone as salvage therapy in patients with relapsed/refractory multiple myeloma: analysis of long-term clinical outcomes. Annals of Hematology. 93(1). 123–128. 12 indexed citations
20.
Cavo, Michèle, et al.. (2013). Role of Consolidation Therapy in Transplant Eligible Multiple Myeloma Patients. Seminars in Oncology. 40(5). 610–617. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Serena Rocchi Breakdown of academic impact, for papers by Xenofon Papanikolaou Breakdown of academic impact, for papers by Josien C. Regelink Breakdown of academic impact, for papers by Ma Teresa Cibeira Breakdown of academic impact, for papers by Vallari Shah Breakdown of academic impact, for papers by María-Victoria Mateos Breakdown of academic impact, for papers by E. Stadtmauer Breakdown of academic impact, for papers by Morten Salomo Breakdown of academic impact, for papers by Cesare Bergonzi Breakdown of academic impact, for papers by Nuria Navarro Coy
Rankless by CCL
2026